Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO was delisted on the 27th of March, 2020.
4 hedge funds and large institutions have $293K invested in Proshares UltraPro NASDAQ Biotechnology in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
33% less funds holding
Funds holding: 6 → 4 (-2)
80% less capital invested
Capital invested by funds: $1.45M → $293K (-$1.16M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$553K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$391K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$47.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$40.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $263K | -$40.9K | -1,821 | -12% |
|
2
Morgan Stanley
New York
| $15K | – | – | – |
|
|
LTFS
3
Ladenburg Thalmann Financial Services
Miami,
Florida
| $14K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$47.8K | -2,128 | -97% |
|
|
5
Jane Street
New York
| – | -$553K | -21,385 | Closed |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$391K | -15,074 | Closed |
|
UBIO Hedge Fund Activity: Q3 2019 in Review
4 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Proshares UltraPro NASDAQ Biotechnology (UBIO) for Q3 2019, worth a combined $293K — down 80% from $1.45M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of UBIO and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $553K sold.
- 4 institutional investors held Proshares UltraPro NASDAQ Biotechnology (UBIO) as of Q3 2019, down from 6 in Q2 2019.
- Funds reported $293K of Proshares UltraPro NASDAQ Biotechnology stock for Q3 2019, down 80% quarter-over-quarter.
- 0 funds opened new Proshares UltraPro NASDAQ Biotechnology positions in Q3 2019 and 2 closed out, a net change of -2 holders.
- The largest Proshares UltraPro NASDAQ Biotechnology seller in Q3 2019 was Jane Street, an estimated $553K sold.
Based on aggregated 13F filings for Q3 2019.